Peptide Registry

GLOW Plus (BPC-157/GHK-Cu/TB-500/TA-1)

Price range: $115.00 through $131.00

  • Contents: GLOW Plus (BPC-157 / GHK-Cu / TB-500 / Thymosin Alpha 1 four-peptide research blend)
  • Form: Lyophilized powder
  • Purity: >99%
Quantity Discount Price
1 - 3 - -
4 - 7 10% -
8 + 18% -
SKU: N/A Category: Brand:

Description

GLOW Plus extends the three-component GLOW blend by adding Thymosin Alpha 1 (TA-1) as a fourth research input. The base components retain their distinct mechanistic roles: BPC-157 operates through the receptor and NO axis via VEGFR2 upregulation and FAK/paxillin signaling; GHK-Cu drives the transcriptional axis through VEGF/bFGF modulation and MMP/TIMP-regulated ECM gene expression; TB-500 addresses the cytoskeletal axis through G-actin sequestration and endothelial cell migration. Thymosin Alpha 1 adds a fourth mechanistic dimension that the original three components do not address: TLR2 and TLR9-mediated innate immune signaling on dendritic cells, driving downstream T-cell maturation and cytokine coordination. This immune axis is mechanistically independent from the vascular and ECM signaling pathways of the other three components, making GLOW Plus appropriate for recovery peptide research models where tissue biology and immune cell signaling are studied as simultaneous experimental variables.

Chemical Information

BPC-157 Component:

  • Chemical Name: BPC-157 (Body Protection Compound 157)
  • Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
  • Molecular Formula: C62H98N16O22
  • Molecular Weight: 1,419.5 g/mol

GHK-Cu Component:

  • Chemical Name: GHK-Cu (Glycyl-L-histidyl-L-lysine copper complex; Copper Tripeptide-1)
  • Sequence: Gly-His-Lys
  • Molecular Formula: C14H24N6O4Cu
  • Molecular Weight: 401.9 g/mol
  • Appearance: Blue powder (characteristic of copper coordination)

TB-500 Component:

  • Chemical Name: TB-500 (Thymosin Beta-4 fragment; Ac-LKKTETQ)
  • Sequence: Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln
  • Molecular Weight: approximately 882 Da

Thymosin Alpha 1 Component:

  • Chemical Name: Thymosin Alpha 1 (TA-1; Zadaxin)
  • Sequence: Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH
  • Molecular Formula: C129H215N33O55
  • Molecular Weight: 3,108.3 g/mol

Blend:

  • Ratio Option 1: BPC-157 5mg / GHK-Cu 50mg / TB-500 2mg / TA-1 3mg
  • Ratio Option 2: BPC-157 10mg / GHK-Cu 50mg / TB-500 10mg / TA-1 5mg
  • Production: Solid-phase peptide synthesis (SPPS) for all peptide components; copper coordination post-synthesis for GHK-Cu

Applications

  • Four-pathway tissue and immune biology research. GLOW Plus provides four mechanistically independent research inputs: receptor/NO axis (BPC-157), transcriptional ECM axis (GHK-Cu), cytoskeletal migration axis (TB-500), and TLR-mediated innate immune axis (TA-1); appropriate for models studying how vascular, ECM, and immune signaling interact in the same experimental system
  • Immune-tissue biology intersection research. TA-1’s TLR2/TLR9 activation on dendritic cells and downstream T-cell maturation effects are mechanistically distinct from the vascular and ECM signaling of the other three components; GLOW Plus enables simultaneous study of immune and tissue signaling inputs that are typically studied in separate experimental systems
  • Angiogenesis and immune modulation combined models. BPC-157 and GHK-Cu both contribute to vascular signaling while TA-1 modulates the immune cell populations that also participate in tissue vascular biology; researchers examining how immune cell activity influences vascular remodeling outcomes use this blend to activate both systems simultaneously
  • Comparative combination research designs. Researchers studying whether TA-1’s immune axis input changes observed outcomes in models previously characterized with the three-component GLOW blend use GLOW Plus as the four-component condition alongside GLOW as the three-component control
  • ECM remodeling with immune context. GHK-Cu’s MMP/TIMP balance and collagen gene regulation operate in an extracellular environment that is also shaped by immune cell activity; GLOW Plus enables study of ECM remodeling under conditions where TA-1-mediated immune signaling is simultaneously active

Storage and Handling

Store lyophilized blend at -20C for long-term stability, or at 2-8C for short-term use. Protect from light, particularly important for the GHK-Cu component whose copper coordination is light-sensitive. The characteristic blue color of the lyophilized powder reflects GHK-Cu copper coordination and is not an indicator of contamination. Reconstitute in bacteriostatic water immediately before use; plain sterile water is acceptable for single-use experiments only. Avoid repeated freeze-thaw cycles. GHK-Cu is the most handling-sensitive component; reconstitution protocol should be optimized for this component. TA-1 is stable under these conditions but should be kept cold and protected from light alongside the other components.

Compliance Notice

GLOW Plus is for laboratory research use only. It is not for human or veterinary use and carries no therapeutic, diagnostic, or clinical indication. This product has not been evaluated by the FDA. By purchasing this product, the buyer confirms that they will follow appropriate institutional safety procedures and use it exclusively for controlled research.

Frequently Asked Questions

What does Thymosin Alpha 1 add to the GLOW blend?

The three GLOW components address vascular and ECM signaling through receptor/NO, transcriptional, and cytoskeletal axes. None of the three directly engages innate immune signaling. Thymosin Alpha 1 adds a fourth mechanistic input through TLR2 and TLR9 activation on dendritic cells, driving downstream T-cell maturation and cytokine coordination. This immune axis is mechanistically independent from the other three, making GLOW Plus appropriate for research models where immune cell signaling is an active experimental variable alongside tissue vascular and ECM biology.

Is there published research on this four-compound combination?

No peer-reviewed study has tested this specific four-compound combination of BPC-157, GHK-Cu, TB-500, and Thymosin Alpha 1 together in any experimental model. Each individual component has its own published literature, and the four-axis mechanistic rationale is grounded in single-compound data. Researchers using GLOW Plus should include single-compound control arms for each component and a three-component GLOW control arm to isolate the contribution of TA-1 to observed outcomes. Without these controls, effects cannot be attributed to specific components or to interaction effects.

How does GLOW Plus differ from GLOW in research design terms?

GLOW is a three-pathway vascular and ECM research blend. GLOW Plus adds TA-1's immune signaling axis as a fourth independent input. The practical difference in research design is the addition of immune cell biology as an active variable: models using GLOW Plus need to account for TA-1's effects on dendritic cell activation and T-cell populations alongside the vascular and ECM effects of the other three components. Researchers whose experimental model does not involve immune cell populations should use GLOW; those studying tissue biology in an immune cell context should use GLOW Plus and include appropriate immune cell readouts alongside vascular and ECM endpoints.